Governance
Investors
About us
Profile
Management
Board
Scientific Advisory Board
Our Science
Strategy
Enabling Technologies
Product Classes
Pipeline
Pipeline
Nidlegy
TM
Fibromun
Darleukin
Dodekin
Dekavil
Onco IX
OncoFAP Radio Conjugates
Tripokin
Press Releases & Media
Press Releases
Events
Philogen in the news
Media Library
Work with us
Careers
Partnering
About us
Profile
Management
Board
Scientific Advisory Board
Our Science
Strategy
Enabling Technologies
Product Classes
Pipeline
Pipeline
Nidlegy
TM
Fibromun
Darleukin
Dekavil
Dodekin
Onco IX
OncoFAP Radio Conjugates
Tripokin
Press Releases & Media
Press Releases
Events
Media Library
Philogen in the news
Work with us
Careers
Partnering
Investors
Investor Relations
Shareholding
IPO
Press Releases
Financial Statements
Financial Calendar
Internal Dealing
Buyback
Analyst Coverage
Webinars
IR Contacts
Governance
Board of Directors
Board of Statutory Auditors
Documents & Procedures
Shareholders’ Meetings
Codice etico e Modello 231
Sustainability (ESG)
News & Events
2023
,
Investors
,
Press Releases
23 gennaio 2023 – Aggiornamento sul programma di acquisto di azioni proprie
Jan 23, 2023
More details
Last News & Events
Nov
2023
7
The Board of Directors approves the net financial position for the third quarter of 2023
Oct
2023
23
23 ottobre 2023 – Aggiornamento sul programma di acquisto di azioni proprie
« Previous
1
2
3
4
5
6
…
111
Next »
